SREBF1 and hyperinsulinism: This acute negative effect of insulin on de novo lipogenesis is in contrast to its chronic lipogenic effect whereby hyperinsulinemia, such as in conditions of elevated visceral/abdominal obesity and type 2 diabetes, activates SREBP-1c, a master transcriptional upregulator of the expression of lipogenic genes, including FASN [7].